CPSAC
NVO

Chas P. Smith & Associates (CPS)’s Novo Nordisk NVO Stock Holding History

Chas P. Smith & Associates (CPS)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.5M Buy
801,586
+230,875
+40% +$10.9M 1.6% 29
2025
Q4 		$29M Buy
570,711
+165,286
+41% +$8.45M 1.53% 28
2025
Q3 		$22.5M Buy
405,425
+207,959
+105% +$12.2M 1.95% 20
2025
Q2 		$13.6M Buy
197,466
+116,413
+144% +$7.92M 0.77% 37
2025
Q1 		$5.63M Buy
+81,053
New +$6.69M 0.33% 43

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Chas P. Smith & Associates (CPS)'s NVO Position: Q1 2026 in Review

Chas P. Smith & Associates (CPS) increased its Novo Nordisk (NVO) stake by 40% in Q1 2026, buying an estimated $10.9M and bringing the position to 801,586 shares worth $29.5M. The position accounts for 1.6% of the portfolio, ranked #29.

Chas P. Smith & Associates (CPS) first reported a position in NVO in Q1 2025 and has held it in 5 quarters since. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Chas P. Smith & Associates (CPS) held 801,586 shares of Novo Nordisk worth $29.5M as of Q1 2026.
  • Chas P. Smith & Associates (CPS) bought 230,875 Novo Nordisk shares in Q1 2026, an estimated $10.9M.
  • Novo Nordisk made up 1.6% of Chas P. Smith & Associates (CPS)'s portfolio in Q1 2026, its #29 holding.
  • Chas P. Smith & Associates (CPS) first reported a position in Novo Nordisk in Q1 2025 and has held it in 5 quarters since.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Chas P. Smith & Associates (CPS)'s 13F filing for Q1 2026, filed 12 May 2026.